Collins: 'Time to Accelerate hESC Research, Not Throw on the Brakes' | GenomeWeb

In this week's issue of The New Yorker, Peter Boyer examines Francis Collins: the political man, and Francis Collins: the devout Christian, paying particular attention to the NIH director's reactions to the recent federal ruling that has frozen federal funding for embryonic stem cell research. Collins also expresses his disappointment over the recent news coverage of the tenth anniversary of the human genome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.